This Article Full Text Full Text (PDF) All Versions of this Article: 145/5/2165    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J. J. Articles by Widmaier, E. P. Search for Related Content PubMed PubMed Citation Articles by Lee, J. J. Articles by Widmaier, E. P.

Reversible Changes in Adrenocorticotropin (ACTH)-Induced Adrenocortical Steroidogenesis and Expression of the Peripheral-Type Benzodiazepine Receptor during the ACTH-Insensitive Period in Young Rats

Department of Biology (J.J.L., J.W., P.E., E.P.W.), Boston University, Boston, Massachusetts 02215; and Department of Biochemistry and Molecular Biology (V.P.), Georgetown University School of Medicine, Washington, D.C. 20007

Address all correspondence and requests for reprints to: Dr. E. P. Widmaier, Department of Biology, Boston University, 5 Cummington Street, Boston, Massachusetts 02215. E-mail: widmaier{at}bu.edu.

We previously demonstrated decreased adrenal content of a mitochondrial cholesterol transporter [peripheral-type benzodiazepine receptor (PBR)] during the first postnatal week in rats, when ACTH-inducible steroidogenesis is low. Here we report that the expression of PBR protein and mRNA increases throughout the neonatal/juvenile period in rats in parallel with ACTH-inducible steroidogenesis in vitro. We also previously reported that chronic stimulation of rat pups with daily ACTH injections augmented the steroidogenic response of the developing adrenal cortex. We therefore tested the hypotheses that the change in phenotype induced by ACTH was permanent, and that the effects of ACTH were mediated by increased PBR expression. Pups were injected with ACTH or saline from postnatal d (pd) 2–8 or 2–14. Another group of pups received ACTH from pd 2–7, followed by saline from pd 8–14. On the final day, all pups were challenged with a test injection of ACTH or saline. Exposure to ACTH, but not saline, for 1 wk significantly increased adrenal mass, the corticosterone response to ACTH, and the expression of PBR protein and mRNA. Continued ACTH treatment for a second week maintained adrenal mass, steroidogenesis, and PBR mRNA expression. When ACTH was withdrawn after 1 wk and replaced with daily saline injections, however, adrenal mass, ACTH-inducible steroidogenesis, and PBR expression returned to levels comparable to those in age-matched saline controls (i.e. animals that had not received ACTH injections during the first 2 wk). Thus, although ACTH was capable of inducing increased steroidogenic capacity of the juvenile rat adrenal, its effects were only manifest when pups were exposed regularly to high plasma ACTH levels. ACTH, therefore, has significant, but reversible, effects on the development of adrenocortical function, possibly mediated in part by increased expression of PBR.

This article has been cited by other articles:

				M. Herman and C. Rivier Activation of a Neural Brain-Testicular Pathway Rapidly Lowers Leydig Cell Levels of the Steroidogenic Acute Regulatory Protein and the Peripheral-Type Benzodiazepine Receptor while Increasing Levels of Neuronal Nitric Oxide Synthase Endocrinology, January 1, 2006; 147(1): 624 - 633. [Abstract] [Full Text] [PDF]